HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Junichirou Nasu Selected Research

CD55 Antigens (Decay Accelerating Factor)

1/2005Stool decay-accelerating factor as a marker for monitoring the disease activity during leukocyte apheresis therapy in patients with refractory ulcerative colitis.
6/2004Complement regulatory proteins in normal human esophagus and esophageal squamous cell carcinoma.
4/2004Enhanced expression of decay-accelerating factor, a complement-regulatory protein, in the specialized intestinal metaplasia of Barrett's esophagus.
3/2004Difference in Ulex europaeus agglutinin I-binding activity of decay-accelerating factor detected in the stools of patients with colorectal cancer and ulcerative colitis.
3/2004Increased serum concentrations and surface expression on peripheral white blood cells of decay-accelerating factor (CD55) in patients with active ulcerative colitis.
11/2003Release of decay-accelerating factor into stools of patients with colorectal cancer by means of cleavage at the site of glycosylphosphatidylinositol anchor.
11/2003Testing of multiple samples increases the sensitivity of stool decay-accelerating factor test for the detection of colorectal cancer.
8/2002Improvements in the measurement of stool decay-accelerating factor in the detection of colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Junichirou Nasu Research Topics

Disease

9Neoplasms (Cancer)
01/2013 - 11/2003
7Colorectal Neoplasms (Colorectal Cancer)
02/2019 - 08/2002
7Stomach Neoplasms (Stomach Cancer)
11/2010 - 04/2003
5Ulcerative Colitis
03/2007 - 03/2004
2Hemorrhage
02/2019 - 09/2006
2Esophageal Neoplasms (Esophageal Cancer)
01/2009 - 06/2004
2Esophageal Squamous Cell Carcinoma
01/2009 - 06/2004
2Lymphatic Metastasis
04/2007 - 05/2006
2Inflammation (Inflammations)
01/2005 - 03/2004
2Chronic Hepatitis (Chronic Active Hepatitis)
06/2002 - 04/2002
1Cancer Pain
08/2021
1Varicose Veins (Varicose Vein)
02/2019
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2009
1Disease Progression
03/2007
1Proctitis
03/2007
1Colitis
03/2007
1Abdominal Pain (Pain, Abdominal)
11/2005
1Neutropenia
08/2005
1Pancreatic Neoplasms (Pancreatic Cancer)
09/2004
1Carcinoma (Carcinomatosis)
06/2004
1Barrett Esophagus (Barrett's Esophagus)
04/2004
1Metaplasia
04/2004
1Infections
09/2003
1Autoimmune Diseases (Autoimmune Disease)
06/2002
1Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
04/2002
1Liver Diseases (Liver Disease)
04/2002

Drug/Important Bio-Agent (IBA)

8CD55 Antigens (Decay Accelerating Factor)IBA
01/2005 - 08/2002
6Complement System Proteins (Complement)IBA
01/2005 - 11/2003
4Proteins (Proteins, Gene)FDA Link
01/2005 - 11/2003
2Fluorouracil (Carac)FDA LinkGeneric
01/2009 - 12/2007
2Messenger RNA (mRNA)IBA
01/2009 - 11/2003
2Irinotecan (Camptosar)FDA LinkGeneric
12/2007 - 09/2004
2EnzymesIBA
08/2002 - 04/2002
2ImmunosorbentsIBA
08/2002 - 04/2002
2Asialoglycoprotein ReceptorIBA
06/2002 - 04/2002
1Opioid Analgesics (Opioids)IBA
08/2021
1Indicators and Reagents (Reagents)IBA
01/2013
1RNA (Ribonucleic Acid)IBA
01/2009
1Cisplatin (Platino)FDA LinkGeneric
01/2009
1Orotate PhosphoribosyltransferaseIBA
01/2009
1Complementary DNA (cDNA)IBA
01/2009
1Leucovorin (Folinic Acid)FDA Link
12/2007
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
07/2007
1Adrenal Cortex Hormones (Corticosteroids)IBA
03/2007
1BariumIBA
11/2005
1Paclitaxel (Taxol)FDA LinkGeneric
08/2005
1doxifluridineIBA
08/2005
1Capecitabine (Xeloda)FDA Link
08/2005
1GemcitabineFDA Link
09/2004
1Membrane Cofactor ProteinIBA
06/2004
1CD59 AntigensIBA
06/2004
1Biomarkers (Surrogate Marker)IBA
04/2004
1AgglutininsIBA
03/2004
1CarbohydratesIBA
03/2004
1Glycoproteins (Glycoprotein)IBA
03/2004
1Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA
11/2003
1GalactosyltransferasesIBA
09/2003
1Gastric MucinsIBA
09/2003
1Uridine Diphosphate (UDP)IBA
09/2003
1titanium silicide (TS-1)IBA
04/2003
1Anti-Idiotypic AntibodiesIBA
06/2002
1AntigensIBA
06/2002
1AutoantibodiesIBA
04/2002
1AntibodiesIBA
04/2002
1Monoclonal AntibodiesIBA
04/2002

Therapy/Procedure

4Gastrectomy
11/2010 - 05/2006
4Therapeutics
01/2005 - 04/2003
1Palliative Care (Palliative Therapy)
08/2021
1Ligation
02/2019
1Chemoradiotherapy
01/2009
1Operative Surgical Procedures
04/2007
1Colectomy
09/2006
1Lymph Node Excision (Lymph Node Dissection)
05/2006
1Treatment Delay
08/2005
1Blood Component Removal (Apheresis)
01/2005